FINWIRES · TerminalLIVE
FINWIRES

SoftBank Group's Net Income More Than Quadruples in Fiscal Year 2025

By

SoftBank Group's (TYO:9984) net income attributable to owners of the parent soared 334% to 5.002 trillion yen in the fiscal year 2025 from 1.153 trillion yen a year earlier.

The investment holding and internet services company's earnings per share increased to 872.47 yen from 194.85 yen a year ago, according to a Tokyo bourse filing on Wednesday.

Net sales climbed 7.7% to 7.799 trillion yen for the year ended March 31 from 7.244 trillion yen in the prior year.

The company declared a final dividend of 5.50 yen per share.

For fiscal year 2026, SoftBank plans to pay interim and year-end dividends of 5.50 yen per share each.

Related Articles

Asia

Singapore Exchange Reports 6% Rise in Securities Market Turnover in April

Singapore Exchange (SGX:S68) reported a 6% year-over-year rise in securities market turnover to SG$43.2 billion in April, according to an after-market filing with the Singapore Exchange on Wednesday.Securities daily average value, or SDAV, also jumped 6% year over year to SG$2.1 billion, while derivatives traded volume edged up 1% on year to 30.2 million contracts, with derivatives daily average volume increasing slightly to about 1.5 million contracts.The steady trading volumes were driven by strong participation in small and mid-cap stocks, with SDAV of those stocks rising 8% month over month.Meanwhile, assets under management across exchange-traded funds or ETFs, crossed SG$20 billion in April, representing a 45% year-over-year surge.

$SGX:S68
Asia

Henlius Biotech Gets Nod for Tumor Drug Trial in Australia

Shanghai Henlius Biotech (HKG:2696) obtained approval for a phase 1 clinical trial of HLX48 for injection from Australia's relevant regulatory authorities, according to a Wednesday Hong Kong bourse filing.The drug will be tested for the treatment of advanced/metastatic solid tumors.

$HKG:2696
Asia

Kabra Extrusiontechnik Appoints Interim CFO

Kabra Extrusiontechnik (NSE:KABRAEXTRU, BOM:524109) has appointed Uttam Singh, currently the deputy general manager-accounts and finance, as the interim chief financial officer, according to a Wednesday filing to the Indian stock exchanges.His appointment is effective from Wednesday till a new CFO is appointed by the board.

$BOM:524109$NSE:KABRAEXTRU